EduFlip vs Lumira
EduFlip
eduflip.orgLumira
lumirareads.comSide by side
| Figure | EduFlip | Lumira |
|---|---|---|
| Price from | $1.08/mo | Free |
| Free plan | Yes | Yes |
| Free trial | Yes | — |
| Open source | — | — |
| Web | Yes | Yes |
| Plans published | 14 | 1 |
| Spec score · Dyslexia Learning Apps | 8.9 (#2) | 7.4 (#20) |
| Integrations | The terms and privacy policy describe possible links or integrations with student-information systems, IEP platforms and single-sign-on providers, without naming specific live connectors. | Lumira says shared-session audio goes directly between participants rather than through a server. |
Plans
EduFlip
- FreeFree
- Professional (501+ students)$13 a year
- Professional (students 501+)$13 a year
- Monthly$14.99 a month
- Professional (151–500 students)$16 a year
- Professional (students 151–500)$16 a year
- Professional (31–150 students)$19 a year
- Professional (students 31–150)$19 a year
- Professional (1–30 students)$22 a year
- Professional (students 1–30)$22 a year
In their own words
EduFlip
EduFlip provides structured literacy instruction based on Orton-Gillingham principles for students with dyslexia. Its curriculum lists 92 lessons across six levels, from foundational skills to advanced patterns and roots. Each lesson follows a five-step structure with controlled, decodable text. The platform records learner responses as mastery data and offers progress dashboards, reports and IEP-compatible exports. It runs in a modern browser on any device, supports offline use and syncs when connectivity returns. EduFlip is presented for schools and districts, therapists and clinics, families and homeschools, and teachers. The Free plan offers Level 1 indefinitely for one student profile. Individual monthly and annual plans include Levels 1–6, one student profile, a parent dashboard, progress reports and IEP-compatible exports; they cost $14.99 a month and $149 a year, respectively. HIPAA-compliant hosting is a paid add-on for qualifying organizations at $350 a month. EduFlip says it does not have peer-reviewed efficacy studies or longitudinal outcome data.